A.A. Elyas

593 total citations
16 papers, 449 citations indexed

About

A.A. Elyas is a scholar working on Pediatrics, Perinatology and Child Health, Psychiatry and Mental health and Cellular and Molecular Neuroscience. According to data from OpenAlex, A.A. Elyas has authored 16 papers receiving a total of 449 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pediatrics, Perinatology and Child Health, 13 papers in Psychiatry and Mental health and 6 papers in Cellular and Molecular Neuroscience. Recurrent topics in A.A. Elyas's work include Epilepsy research and treatment (13 papers), Pharmacological Effects and Toxicity Studies (13 papers) and Neuroscience and Neuropharmacology Research (5 papers). A.A. Elyas is often cited by papers focused on Epilepsy research and treatment (13 papers), Pharmacological Effects and Toxicity Studies (13 papers) and Neuroscience and Neuropharmacology Research (5 papers). A.A. Elyas collaborates with scholars based in United Kingdom and India. A.A. Elyas's co-authors include Philip N. Patsalos, Joanna M. Zakrzewska, P. T. Lascelles, PN Patsalos, Martin Prevett, John S. Duncan, Thomas T. Warner, E M Brett, J. F. Schoeman and Neville Ratnaraj and has published in prestigious journals such as The Lancet, Journal of Neurology Neurosurgery & Psychiatry and The Analyst.

In The Last Decade

A.A. Elyas

16 papers receiving 420 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A.A. Elyas United Kingdom	12	375	366	78	74	34	16	449
G. P. Menge Switzerland	8	316 0.8×	320 0.9×	92 1.2×	74 1.0×	21 0.6×	10	397
A. Fazio Italy	14	288 0.8×	297 0.8×	73 0.9×	50 0.7×	56 1.6×	26	411
Hisao Miura Japan	9	327 0.9×	299 0.8×	44 0.6×	58 0.8×	52 1.5×	36	471
Uwe Jürgens Germany	17	526 1.4×	525 1.4×	220 2.8×	157 2.1×	81 2.4×	28	789
Dave Berry United Kingdom	8	388 1.0×	381 1.0×	58 0.7×	97 1.3×	120 3.5×	12	603
J. C. Van Meter United States	9	237 0.6×	243 0.7×	36 0.5×	81 1.1×	32 0.9×	14	392
Philip N. Patsalos United Kingdom	8	384 1.0×	435 1.2×	92 1.2×	191 2.6×	52 1.5×	8	614
John H. Tyrer Australia	8	176 0.5×	160 0.4×	42 0.5×	30 0.4×	30 0.9×	15	403
Elisabeth Korn‐Merker Germany	12	342 0.9×	367 1.0×	65 0.8×	73 1.0×	55 1.6×	16	461
M. Theisohn Germany	12	158 0.4×	103 0.3×	37 0.5×	29 0.4×	49 1.4×	27	448

Countries citing papers authored by A.A. Elyas

Since Specialization

Citations

This map shows the geographic impact of A.A. Elyas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.A. Elyas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.A. Elyas more than expected).

Fields of papers citing papers by A.A. Elyas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A.A. Elyas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.A. Elyas. The network helps show where A.A. Elyas may publish in the future.

Co-authorship network of co-authors of A.A. Elyas

This figure shows the co-authorship network connecting the top 25 collaborators of A.A. Elyas. A scholar is included among the top collaborators of A.A. Elyas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A.A. Elyas. A.A. Elyas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Elyas, A.A., Jim Iley, & PN Patsalos. (1999). IN VITRO MICRODIALYSIS MONITORING OF FREE (NONPROTEIN BOUND) ANTIEPILEPTIC DRUG LEVELS. Therapeutic Drug Monitoring. 21(4). 451–451. 1 indexed citations

O’Connell, Mark T., et al.. (1995). A Comparison of the OPUS and TDx Analysers for Antiepileptic Drug Monitoring. Therapeutic Drug Monitoring. 17(5). 549–555. 8 indexed citations

Warner, Thomas T., Philip N. Patsalos, Martin Prevett, A.A. Elyas, & John S. Duncan. (1992). Lamotrigine-induced carbamazepine toxicity: an interaction with carbamazepine-10,11 -epoxide. Epilepsy Research. 11(2). 147–150. 98 indexed citations

Patsalos, PN, Joanna M. Zakrzewska, & A.A. Elyas. (1990). Dose dependent enzyme induction by oxcarbazepine?. European Journal of Clinical Pharmacology. 39(2). 187–188. 67 indexed citations

Patsalos, Philip N., A.A. Elyas, & Joanna M. Zakrzewska. (1990). Protein binding of oxcarbazepine and its primary active metabolite, 10-hydroxycarbazepine, in patients with trigeminal neuralgia. European Journal of Clinical Pharmacology. 39(4). 413–415. 38 indexed citations

Elyas, A.A., et al.. (1990). Simple and rapid micro-analytical high-performance liquid chromatographic technique for the assay of oxcarbazepine and its primary active metabolite 10-hydroxycarbazepine. Journal of Chromatography B Biomedical Sciences and Applications. 528(2). 473–479. 16 indexed citations

Patsalos, Philip N., et al.. (1987). Carbamazepine and Carbamazepine-10,11-epoxide Pharmacokinetics in an Overdose Patient. Human Toxicology. 6(3). 241–244. 23 indexed citations

Elyas, A.A., et al.. (1986). Factors Influencing Simultaneous Concentrations of Total and Free Carbamazepine and Carbamazepine-10, 11-Epoxide in Serum of Children with Epilepsy. Therapeutic Drug Monitoring. 8(3). 288–292. 32 indexed citations

Elyas, A.A., et al.. (1986). Total and Free Serum Concentrations of Carbamazepine and Carbamazepine-10,11-Epoxide in Children With Epilepsy. Archives of Neurology. 43(11). 1111–1116. 11 indexed citations

10.

Patsalos, PN, et al.. (1985). SIDE-EFFECTS INDUCED BY CARBAMAZEPINE-10, 11-EPOXIDE. The Lancet. 326(8469-8470). 1432–1432. 14 indexed citations

11.

Patsalos, Philip N., et al.. (1985). The interaction of denzimol (a new anticonvulsant) with carbamazepine and phenytoin.. Journal of Neurology Neurosurgery & Psychiatry. 48(4). 374–377. 10 indexed citations

12.

Schoeman, J. F., A.A. Elyas, E M Brett, & P. T. Lascelles. (1984). CORRELATION BETWEEN PLASMA CARBAMAZEPINE‐10,11‐EPOXIDE CONCENTRATION AND DRUG SIDE‐EFFECTS IN CHILDREN WITH EPILEPSY. Developmental Medicine & Child Neurology. 26(6). 756–764. 54 indexed citations

13.

Schoeman, J. F., A.A. Elyas, E M Brett, & P. T. Lascelles. (1984). ALTERED RATIO OF CARBAMAZEPINE‐10,11‐EPOXIDE/CARBAMAZEPINE IN PLASMA OF CHILDREN: EVIDENCE OF ANTICONVULSANT DRUG INTERACTION. Developmental Medicine & Child Neurology. 26(6). 749–755. 19 indexed citations

14.

Elyas, A.A., et al.. (1982). Routine monitoring of carbamazepine and carbamazepine-10,11-epoxide in plasma by high-performance liquid chromatography using 10-methoxycarbamazepine as internal standard. Journal of Chromatography B Biomedical Sciences and Applications. 231(1). 93–101. 33 indexed citations

15.

Ratnaraj, Neville, et al.. (1981). Determination of diazepam and its major metabolites using high-performance liquid chromatography. The Analyst. 106(1266). 1001–1001. 10 indexed citations

16.

Elyas, A.A., et al.. (1980). Valproic Acid Estimation by Enzyme Immunoassay. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 17(6). 307–310. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact